Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 38 (RN7SKP38) is a processed pseudogene of the human gene for 7SK small nuclear RNA (RN7SK). Pseudogenes are copies of genes that have lost their ability to code for functional products due to accumulated mutations. RN7SKP38 does not encode a functional RNA or protein and lacks known biological function, role in disease, or relevance as a therapeutic target. Its designation as a pseudogene distinguishes it from the functional RN7SK gene, which produces a non-coding RNA involved in regulating transcription elongation via interaction with the P-TEFb transcription factor complex. There is no evidence that RN7SKP38 is expressed or biologically active, and it is not considered a molecular target for therapeutic drug development[3][4][1]. Key notes: - RN7SKP38 is a nonfunctional, noncoding pseudogene and not a protein, enzyme, transporter, or recognized therapeutic target. - The true functional gene is RN7SK, encoding a regulatory small nuclear RNA[1][4]. - There are numerous RN7SK pseudogenes in the genome; none are known to have clinical significance or molecular targeting value[3]. In summary: RN7SK pseudogene 38 (RN7SKP38) is a noncoding, nonfunctional RNA pseudogene with no known biological role or disease association, and is not a therapeutic target. It is appropriate to flag this entity as incorrect for most drug discovery or target validation purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 38 (RN7SKP38).